Stay updated on PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.

Latest updates to the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the change log.SummaryDifference0.0%

- Check25 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3. This appears to be a minor version update with no impact on study details.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.2. Removed outdated notices about government funding and operating status (for example, cc.nih.gov updates).SummaryDifference0.4%

- Check61 days agoChange DetectedThe page now shows a system notice about a lapse in government funding and that the NIH Clinical Center is open, with links to cc.nih.gov and opm.gov for status updates. The page also shows a revision from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check68 days agoChange DetectedShow glossary is now available, and the study record dates include Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The previous entries Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 have been removed.SummaryDifference0.2%

- Check82 days agoChange DetectedThe page shows a minor revision update: Revision: v3.3.4 was added and Revision: v3.3.3 was removed, with no changes to study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PI3K/Akt Suppression vs MK-3475 in Glioblastoma Clinical Trial page.